An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study

This study has been completed.
Sponsor:
Collaborator:
Hellenic Cardiovascular Research Society
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01061086
First received: February 1, 2010
Last updated: December 20, 2011
Last verified: December 2011

February 1, 2010
December 20, 2011
January 2010
June 2010   (final data collection date for primary outcome measure)
  • To evaluate the proportion of patients who are on target for LDL-C according to the 2004-updated NCEP ATPIII guidelines as calculated within the first 24-hours of hospital admission for an ACS. [ Time Frame: first visit - 1st day (cross-sectional part) ] [ Designated as safety issue: No ]
  • To estimate the proportion of patients enrolled in the cross-sectional part of the study that experiences a Major Adverse Cardiovascular Event (MACE) within a 6-month follow-up period. [ Time Frame: follow up visit - 6th month (prospective part) ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01061086 on ClinicalTrials.gov Archive Site
  • To estimate the proportion of patients admitted to the hospital with STEMI, NSTEMI and unstable angina. [ Time Frame: first visit - 1st day (cross-sectional part) ] [ Designated as safety issue: No ]
  • To estimate the "pain-to-door-time" throughout different regions in Greece. [ Time Frame: first visit - 1st day (cross-sectional part) ] [ Designated as safety issue: No ]
  • To estimate the time to first MACE and to estimate CV, non-CV and all cause mortality within the 6-month period following the index ACS event. [ Time Frame: follow up visit - 6th month (prospective part) ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study
An Epidemiological Study of Acute Coronary Syndromes in The Greek Population

This is a multicenter, 2-phase observational study of acute coronary syndromes (ACS) in Greece, designed to provide real world data on the risk factors of patients presenting to a hospital emergency department with an index event, as well as to depict the current management practices and outcomes of these clinical conditions in Greece.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Emergency Room

Acute Coronary Syndromes
Not Provided
1
Patients over 18 years old admitted to the hospital with Acute Coronary Syndrome.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
418
February 2011
June 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of an ACS (STEMI, NSTEMI, UA).
  • Informed Consent

Exclusion Criteria:

  • Involvement in the planning and conduct of the study (applies to both AstraZeneca staff and staff at the study sites).
  • Participation in other clinical study in period between the index event and 6- month follow-up assessment with the exception of registering in registries or surveys not influencing the management of the ACS.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Greece
 
NCT01061086
NIS-CGR-DUM-2009/1
No
AstraZeneca
AstraZeneca
Hellenic Cardiovascular Research Society
Study Director: Panagiotis Pontikis AstraZeneca
AstraZeneca
December 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP